Mechanism of osteogenic differentiation of umbilical cord mesenchymal stem cells
Abstract
Mesenchymal stem cells (MSCS) exist in a variety of tissues and have multi-lineage differentiation potential. Mesenchymal stem cells have great application prospects in the treatment of bone injury diseases. The rapid initiation and efficient induction of osteogenic signaling pathways are the key to mesenchymal stem cell-based bone tissue engineering technology. Multiple signaling pathways have been confirmed to play a regulatory role in the process of osteogenic differentiation of mesenchymal stem cells. This article reviews the research progress of the mechanism of osteogenic differentiation of mesenchymal stem cells.
References
[1] Bai L H, Bao T Y, Shi X M, et al. Effects of 17β-estradiol and vitamin K_2 on osteogenic differentiation of human umbilical cord
mesenchymal stem cells [J]. Systems Med, 2023, 8 (18): 26-30. (in Chinese) DOI:10.19368/j.cnki.2096-1782.2023.18.026.
[2] Xie Ting, Liu Tingting, Zeng Xuehui, et al.Vitamin D3 promotes osteogenic differentiation of human umbilical cord mesenchymal
stem cells by reducing oxidative stress induced by high glucose exposure [J]. Chinese Tissue Engineering Research, 2024, 28 (19): 2981-
2987.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
